The City of Hope Radiation Oncology Residency Program is a four-year Accreditation Council for Graduate Medical Education (ACGME) accredited program which begins in the PGY-2 year. The overall goal of the program is to train physicians to be outstanding radiation oncologists and to provide graduates with a solid foundation in translational and clinical research. The program emphasizes preparation for careers in academic radiation oncology. The selection process gives preference to those applicants who show an aptitude for academic medicine and with an interest in teaching, research and the application of cutting-edge translational technologies to cancer care.
Training is provided in clinical radiation oncology, treatment planning, radiation physics, and radiobiology, equipping graduates to provide comprehensive patient care as practicing radiation oncologists either in academia or the private practice setting. Residents actively participate in the management of a diverse variety of patients, with progressively increasing responsibilities during later phases of the Program. The attending physicians and the resident physicians work as a team, with the resident assuming primary care responsibilities for patients under the attending’s supervision. The resident-attending teams evaluate and counsel new patients and provide treatment which includes radiotherapy simulation, treatment planning, and administration of irradiation. The resident physician follows the patient throughout treatment with attending supervision and subsequently in post-radiotherapy follow-up clinics.
Please refer to Resident Handbook for complete outline of Program Year Objectives.
The total complement of residents is four, with one resident currently being accepted per year into the program. The program participates in the National and Resident Matching Program, with applications processed through the Electronic Residency Application Service (ERAS) common application program. (Refer to Application Process for more information)
City of Hope continues to be on the forefront of the latest treatment technology and clinical research, providing residents with a rich and comprehensive training environment. As an NCI designated comprehensive cancer center and charter member of the NCCN, City of Hope provides an excellent environment for residency education. A major and extensive renovation is underway that will increase the clinical area to 29,000 square feet with 4 treatment vaults, 3 imaging suites, a new clinic area and expansion of treatment planning and physics work space. Two Tomotherapy units, a Varian Trilogy and Varian IX will be installed. Multimodality functional tumor imaging will be a key part of the new center which will house MRI, PET/CT and CT units dedicated to treatment planning and treatment response assessment. In addition to these resources, radiation biology labs occupying a total of 4-5000 square feet currently house the labs of 4 NCI funded basic lab scientists. Finally an additional 8000 square feet is dedicated to an established radioimmunotherapy program with basic science laboratories and a radiopharmacy for the labeling of preclinical and clinical radiopharmaceuticals for tumor imaging and targeted tumor therapy.
Formal lectures cover radiation biology, physics, and clinical radiation oncology. clinical trial design, biostatistics, imaging (PET, SPECT, MRI, etc.), medical oncology and pediatric oncology. Multidisciplinary training will be emphasized. City of Hope has established fellowship programs in medical oncology, hematologic oncology, pathology, surgery, and urology. Ample interaction occurs through clinical conferences and tumor boards. Electives will be available with the other oncologic specialties.
Each resident will also be required to do an 8-12 month research rotation. He or she will select a lab or clinical research project to pursue, with the goal of publishing at least 2 manuscripts in peer-reviewed journals.
In accordance with the American Board of Radiology (ABR) for board eligibility, City of Hope requires successful completion of a clinical PGY1 year in the United States prior to commencing its four-year Radiation Oncology Residency Program.